Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 327,317,888
  • Shares Outstanding, K 2,533,028
  • Annual Sales, $ 60,115 M
  • Annual Income, $ 365,000 K
  • 60-Month Beta 0.38
  • Price/Sales 5.48
  • Price/Cash Flow 43.13
  • Price/Book 8.83
Trade MRK with:

Options Overview Details

View History
  • Implied Volatility 16.57% ( -1.44%)
  • Historical Volatility 19.04%
  • IV Percentile 2%
  • IV Rank 7.06%
  • IV High 26.55% on 10/20/23
  • IV Low 15.81% on 02/06/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 11,736
  • Volume Avg (30-Day) 18,101
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 358,123
  • Open Int (30-Day) 405,036

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 2.14
  • Number of Estimates 8
  • High Estimate 2.25
  • Low Estimate 1.96
  • Prior Year -2.06
  • Growth Rate Est. (year over year) +203.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
124.50 +3.45%
on 04/18/24
132.80 -3.01%
on 04/25/24
-2.19 (-1.67%)
since 04/01/24
3-Month
119.23 +8.03%
on 03/15/24
133.10 -3.23%
on 03/27/24
+2.42 (+1.91%)
since 02/01/24
52-Week
99.14 +29.92%
on 10/19/23
133.10 -3.23%
on 03/27/24
+12.46 (+10.71%)
since 05/01/23

Most Recent Stories

More News
Stocks Retreat as Persistent Inflation Dents Fed Rate-Cut Hopes

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.55%. US stock...

$SPX : 5,018.39 (-0.34%)
SPY : 500.35 (-0.32%)
$DOWI : 37,903.29 (+0.23%)
DIA : 378.89 (+0.20%)
$IUXX : 17,318.55 (-0.70%)
QQQ : 421.52 (-0.72%)
ZNM24 : 107-280 (-0.22%)
META : 439.19 (+2.10%)
AMZN : 179.00 (+2.29%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
TXT : 84.77 (+0.21%)
Merck (MRK) Q1 2024 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2024.

MRK : 128.80 (-0.33%)
Stocks Lower on Tech Stocks Weakness and Stagflation Fears

The S&P 500 Index ($SPX ) (SPY ) is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.6%. US stock indexes are lower, led...

$SPX : 5,018.39 (-0.34%)
SPY : 500.35 (-0.32%)
$DOWI : 37,903.29 (+0.23%)
DIA : 378.89 (+0.20%)
$IUXX : 17,318.55 (-0.70%)
QQQ : 421.52 (-0.72%)
ZNM24 : 107-280 (-0.22%)
META : 439.19 (+2.10%)
AMZN : 179.00 (+2.29%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
TXT : 84.77 (+0.21%)
Stocks Tumble on Tech Stock Weakness and Signs of Persistent Inflation

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.83%. US stock indexes...

$SPX : 5,018.39 (-0.34%)
SPY : 500.35 (-0.32%)
$DOWI : 37,903.29 (+0.23%)
DIA : 378.89 (+0.20%)
$IUXX : 17,318.55 (-0.70%)
QQQ : 421.52 (-0.72%)
ZNM24 : 107-280 (-0.22%)
META : 439.19 (+2.10%)
AMZN : 179.00 (+2.29%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
TXT : 84.77 (+0.21%)
Merck: Q1 Earnings Snapshot

Merck: Q1 Earnings Snapshot

MRK : 128.80 (-0.33%)
MKKGY : 31.6300 (-0.47%)
Stocks Plunge Before the Open as Meta’s Revenue Forecast Disappoints, U.S. GDP Data and Earnings in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.53%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.87% this morning as a disappointing revenue outlook for the current quarter from Meta weighed...

ESM24 : 5,070.50 (+0.48%)
NQM24 : 17,539.00 (+0.58%)
META : 439.19 (+2.10%)
TSLA : 179.99 (-1.80%)
HAS : 60.34 (-1.57%)
TXN : 175.20 (-0.69%)
ODFL : 182.49 (+0.43%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
MRK : 128.80 (-0.33%)
GILD : 65.51 (+0.48%)
CAT : 331.07 (-1.05%)
Navigating the Surge in Aquaculture: Opportunities & Challenges

USA News Group – The way we get our food is in need of a dramatic overhaul, with domestic food inflation remaining high across the globe. However, one aspect of the world’s food supply that’s set...

BIOV.CN : 0.0700 (-6.67%)
BVAXF : 0.0579 (+1.94%)
MRK : 128.80 (-0.33%)
ZTS : 158.50 (-0.46%)
CTVA : 53.91 (-0.41%)
BG : 100.95 (-0.80%)
Option Volatility And Earnings Report For April 22 - 26

We’re all set for a massive week of earnings with with 52 companies of interest reporting. That’s the most in one week I can remember for a long time and is sure to have a big impact on where the market...

TSLA : 179.99 (-1.80%)
AMZN : 179.00 (+2.29%)
META : 439.19 (+2.10%)
MSFT : 394.94 (+1.44%)
GOOGL : 163.86 (+0.66%)
XOM : 116.03 (-1.89%)
V : 267.32 (-0.48%)
MRK : 128.80 (-0.33%)
BA : 171.46 (+2.16%)
DKNG : 41.82 (+0.63%)
ARM : 95.29 (-5.85%)
AMD : 144.27 (-8.91%)
New Home Sales Due Next Week in Canada

Monday U.S. Featured Earnings Verizon Communications Inc. (NYSE:VZ) (Q1) EPS of $1.12, ...

PSK.TO : 25.74 (-1.87%)
CDNS : 274.55 (-0.39%)
TFC : 38.05 (+1.33%)
TSLA : 179.99 (-1.80%)
V : 267.32 (-0.48%)
META : 439.19 (+2.10%)
TMO : 574.99 (+1.10%)
IBM : 164.43 (-1.06%)
ARE.TO : 16.76 (-0.89%)
MSFT : 394.94 (+1.44%)
AMZN : 179.00 (+2.29%)
MRK : 128.80 (-0.33%)
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and

/CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab),...

MRK : 128.80 (-0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda,...

See More

Key Turning Points

3rd Resistance Point 132.02
2nd Resistance Point 130.97
1st Resistance Point 129.89
Last Price 128.80
1st Support Level 127.76
2nd Support Level 126.71
3rd Support Level 125.63

See More

52-Week High 133.10
Last Price 128.80
Fibonacci 61.8% 120.13
Fibonacci 50% 116.12
Fibonacci 38.2% 112.11
52-Week Low 99.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar